Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6011.5000 -59.50 (-0.98%)
NSE Jan 23, 2026 15:31 PM
Volume: 460.5K
 

6011.50
-0.98%
ICICI Securities Limited
EBITDA margins improved 159 bps to 35.5% (I-direct estimate of 33.7%) mainly due to strong gross margins and lower other expenditure. Gross margins improved 200 bps to 62.5% (I-direct...
Divi's Laboratories Ltd. is trading below all available SMAs
More from Divi's Laboratories Ltd.
Recommended